Skip to main content
HEALIOS K.K. logo

HEALIOS K.K. — Investor Relations & Filings

Ticker · 4593 ISIN · JP3835100003 LEI · 3538005FFIDTDLUZOE53 T Professional, scientific and technical activities
Open in API
Filings indexed 78 across all filing types
Latest filing 2026-06-09 Legal Proceedings Report
Country JP Japan
Listing T 4593

About HEALIOS K.K.

https://www.healios.co.jp/en/

Healios K.K. is a clinical-stage biotechnology company specializing in the research and development of regenerative medicine and cell-based therapies. The company's pipeline is focused on addressing unmet medical needs in multiple therapeutic areas. Its lead programs include an allogeneic stem cell product in late-stage clinical development for ischemic stroke and Acute Respiratory Distress Syndrome (ARDS). Healios also leverages its proprietary induced pluripotent stem cell (iPSC) platform to develop next-generation treatments. This platform includes retinal pigment epithelium (RPE) cells for age-related macular degeneration and engineered natural killer (eNK) cells designed to target solid tumors. A key area of its research is the creation of Universal Donor Cells (UDCs) to produce hypoimmunogenic therapies.

Recent filings

Filing Released Lang Actions
当社への訴訟に対する反訴提起に関するお知らせ
Legal Proceedings Report Classification · 93% confidence The document is a formal notice from the company regarding the filing of a counterclaim in an existing litigation (“当社への訴訟に対する反訴提起に関するお知らせ”). It details court, parties, amounts, and legal background, which is a legal proceedings update. This matches the Legal Proceedings Report category.
2026-06-09 Japanese
Notice Regarding the Filing of a Counterclaim in Response to a Lawsuit Filed Against Healios
Legal Proceedings Report Classification · 88% confidence The document is a regulatory announcement detailing the company’s filing of a counterclaim in an ongoing lawsuit. It provides facts about the court, the parties, the nature and background of the claim, and future outlook. There are no financial statements, governance materials, or earnings data. This falls squarely under Legal Proceedings Report (updates on significant lawsuits or legal matters).
2026-06-09 English
NEDO公募課題「ＡＩの安全性確保に関する研究開発・検証等の推進事業」開発成果の発表に関するお知らせ
Regulatory Filings Classification · 20% confidence The document is a Japanese press release by Helios Corporation announcing the development results of a NEDO‐funded AI safety research project. It is not a financial report, earnings release, board change, share issuance, or investor presentation, nor does it reference the release of a formal company report. As it does not fit any specialized filing category, it falls into the fallback “Regulatory Filings” category (RNS).
2026-05-28 Japanese
臨時報告書
Regulatory Filings Classification · 85% confidence The document is titled “臨時報告書” filed under the Japanese Financial Instruments and Exchange Act (FIEA) Article 24-5 and Cabinet Office Ordinance disclosure rules, indicating an extraordinary event disclosure rather than a full interim/quarterly report. It provides event details and limited impact numbers but does not contain comprehensive financial statements or narrative analysis that would categorize it as an Interim/Quarterly Report (IR). It is a mandatory regulatory disclosure of a specific event, fitting the fallback “Regulatory Filings” category.
2026-05-14 Japanese
FY2026 Q1 Financial Results (Material)
Regulatory Filings
2026-05-14 English
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO and CFO regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 15
2026-03-24 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.